IP Library Granted Patent US 9,441,224
Granted Patent B1
US 9,441,224 · App. 14/120,786 · Granted Sep 13, 2016

Long noncoding RNAS and cell reprogramming and differentiation

Inventors: Daniel H. Kim (Los Angeles, CA); Barbara J. Wold (San Marino, CA)
Assignee: CALIFORNIA INSTITUTE OF TECHNOLOGY
C12N15/113A61K31/713C12N2310/14C12N2310/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,441,224
App. No.
14/120,786
Granted
Sep 13, 2016
Kind
B1
Abstract

Long noncoding RNAs (lncRNAs) are identified that enhance pluripotency reprogramming of somatic cells as well as differentiation of pluripotent cells. Induced pluripotent stem (iPS) cell generation from somatic cells leads to the upregulation and downregulation of identified lncRNAs. The modulation of these lncRNAs are capable of enhancing pluripotency of somatic cells as well as enhancing differentiation of a pluripotent cell.

Claims (10)

1. A method of enhancing reprogramming of a somatic cell to a pluripotent cell in a human or mouse, comprising:

upregulating in the somatic cell at least one long noncoding RNA (lncRNA) selected from SEQ ID NOs. 43, 272, 304, 334, 345, 395, and homologs thereof having at least 85% homology to the at least one lncRNA, the upregulating comprising adding or activating the at least one lncRNA.

2. The method of claim 1 , wherein the adding or activating comprises contacting the somatic cell with the at least one synthetic lncRNA and/or a vector encoding the at least one lncRNA.

3. The method of claim 1 , further comprising downregulating in the somatic cell at least one lncRNA selected from SEQ ID NOs. 361, 408, 414, 415, 418, 419, and homologs thereof having at least 85% homology to the at least one lncRNA, the downregulating comprising contacting the somatic cell with antisense oligonucleotides and/or interfering RNA (RNAi) targeting the at least one lncRNA.

4. The method of claim 3 , wherein the somatic cell is human and the upregulating of the at least one lncRNA comprises upregulating lncRNAs selected from SEQ ID NOs. 334, 345, 395, and the homologs thereof having at least 85% homology to the at least one lncRNA, and the downregulating of the at least one lncRNA comprises contacting the somatic cell with antisense oligonucleotides and/or interfering RNAi targeting the at least one lncRNA selected from SEQ ID NOs. 361, 408, 414, and the homologs thereof having at least 85% homology to the at least one lncRNA.

5. The method of claim 1 , further comprising expressing Oct 4, Sox2, Klf4, and c-Myc transcription factors in the somatic cell.

6. The method of claim 1 , wherein the homologs have at least 90% homology.

7. A method of enhancing differentiation of a cell in a pluripotent state in a human or mouse, comprising:

downregulating in the cell at least one long noncoding RNA (lncRNA) selected from SEQ ID NOs. 272, 304, 334, 395, and homologs thereof having at least 85% homology to the at least one lncRNA, the downregulating comprising contacting the cell with antisense oligonucleotides and/or interfering RNA (RNAi) targeting the at least one lncRNA.

8. The method of claim 7 , further comprising upregulating at least one lncRNA selected from SEQ ID NOs. 361, 408, 414, 415, 418, 419, and homologs thereof having at least 85% homology to the at least one lncRNA, the upregulating comprising adding or activating the at least one lncRNA.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2015
From: KIM, DANIEL H.; WOLD, BARBARA J.
To: CALIFORNIA INSTITUTE OF TECHNOLOGY
Reel/Frame 036033/0844 →
CONFIRMATORY LICENSE Recorded Sep 11, 2014
From: CALIFORNIA INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 033721/0382 →
Continuity (1)
Provisional Application 61840306 · Jun 27, 2013